InMed Pharmaceuticals

INM
Request Investor Info

IntegraSynTM is InMed’s integrated cannabinoid manufacturing system. It uses multiple standard pharmaceutical processes to enable the production of cannabinoids with bio-identical structures as compared to those found in nature.

Projects
Stories
Presentation
Contact
Management
Financials
InMed Pharmaceuticals Stock Price Today
InMed Pharmaceuticals Fundamental Data by TradingView

Company Feed

InMed Pharmaceuticals cannabinoids
Cannabis
February 24, 2021

InMed Pharmaceuticals: An Optimized System to Cannabinoid Manufacturing

While rare cannabinoids may hold tremendous potential as new treatments for diseases with high unmet medical needs, it is not economically feasible to …

This is some text inside of a div block.
InMed Pharmaceuticals cannabinoid
Cannabis
January 20, 2020

BTV News Alert: InMed Advances a Rare Cannabinoid that Could Treat Skin & Ocular Diseases

InMed Pharmaceuticals is a biopharmaceutical company. They specialize in the discovery and development of novel, cannabinoid-based therapeutics for th …

This is some text inside of a div block.
InMed Pharmaceuticals cannabinoids InMed Pharmaceuticals cannabinoids
Cannabis
January 10, 2020

InMed Pharmaceuticals: Leading the Way in Rare Cannabinoids

InMed Pharmaceuticals is a leader in developing rare cannabinoids and their potential to treat serious skin and eye diseases. They are a clinical-stag …

This is some text inside of a div block.
Biologically Identical Cannabinoids
Cannabis
February 22, 2019

InMed Pharmaceuticals Producing Cannabinoids Without the Plant!

A biosynthesis platform technology Cannabinoids are relative compounds that are the active elements of the cannabis plant. While there are over 100 di …

This is some text inside of a div block.
Subscribe and receive the investor Info